Results 251 to 260 of about 347,609 (391)
Glucagon-Like Peptide-1 Receptor Agonists Lead to Gastrointestinal Benefits in Patients with Type 2 Diabetes: A Real-World Study. [PDF]
Hsu JH+6 more
europepmc +1 more source
Pharmacotherapy for Cirrhosis in Japan
As cirrhosis progresses from the compensated to the decompensated stage, liver disease‐related events such as varices, ascites, encephalopathy, sarcopenia, jaundice, and bleeding tendency, as well as liver carcinogenesis, can occur at a high rate. With the advent of new pharmacotherapies for cirrhosis in the last decade, liver fibrosis has been shown ...
Hiroki Nishikawa, Soo Ki Kim, Akira Asai
wiley +1 more source
Risk of Biliary Tract and Pancreatic Cancer Following Obstructive Sleep Apnea Diagnosis: Analysis of a National Health Insurance Database. [PDF]
Park MJ+5 more
europepmc +1 more source
ABSTRACT Background Approximately 50% of prostate cancer (PCa) patients meet the National Comprehensive Cancer Network (NCCN) guidelines for germline testing at diagnosis. However, the selection of genes for testing, their supporting evidence, and clinical interpretation remain poorly understood.
Jianfeng Xu+19 more
wiley +1 more source
Global burden of gallbladder and biliary diseases (1990-2021) with healthcare workforce analysis and projections to 2035. [PDF]
Dai F, Cai Y, Yang S, Zhang J, Dai Y.
europepmc +1 more source
ABSTRACT Linerixibat, an ileal bile acid transporter (IBAT) inhibitor, is being evaluated for the treatment of pruritus in primary biliary cholangitis (PBC). Diarrhea is commonly reported with this drug class as IBAT inhibition redirects bile acids (BA) to the colon.
Fernando Carreño+4 more
wiley +1 more source
Endoscopic ultrasound-guided rendezvous technique with dual endoscopic technique rescue the difficult cannulation after Billroth type II gastrectomy. [PDF]
Tian J+6 more
europepmc +1 more source
Serum Glutamic Oxalacetic Transaminase in Diseases of the Liver and Biliary Tract [PDF]
S Madsen, Nils U. Bang, K Iversen
openalex +1 more source